SCHEMBL4704534

SCHEMBL4704534

CC(=O)Nn1c(=O)c(=O)[nH]c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 5/20 0.50
GRIK3 Q13003 4/20 0.50
GRIK2 Q13002 3/20 0.50
GRIK1 P39086 3/20 0.46
GRIK5 Q16478 2/20 0.46
GRIA1 P42261 3/20 0.45
GRIA3 P42263 3/20 0.45
GRIA4 P48058 3/20 0.45
PARP1 P09874 1/20 0.42
KDM4E B2RXH2 3/20 0.42
POLB P06746 3/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPT P10636 1/20 0.42
DAO P14920 1/20 0.41
TSHR P16473 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7584641 0.85 GRIA2 (0.44) GRIA2GRIK3GRIK2GRIK1GRIK5
SCHEMBL6583745 0.84 DAO (0.51) KDM4EPOLBALDH1A1HPGDHSD17B10
SCHEMBL4705859 0.78 MPO (0.48) GRIA2GRIK3GRIK2KDM4EPOLB
SCHEMBL8372771 0.76 GRIA2 (0.40) GRIA2GRIK3GRIK2GRIK1GRIK5
SCHEMBL4706735 0.74 PSMB8 (0.55) GRIA2GRIA1GRIA3GRIA4PARP1
SCHEMBL29580191 0.74 PSMB8 (0.55) GRIA2GRIA1GRIA3GRIA4PARP1
SCHEMBL11407185 0.72 L3MBTL1 (0.58) KDM4EPOLBALDH1A1HPGDHSD17B10
SCHEMBL7779726 0.71 GRIA1 (0.47) GRIA2GRIA1GRIA3GRIA4PARP1
SCHEMBL7349965 0.71 DAO (0.66) GRIA2GRIA1GRIA3GRIA4PARP1
SCHEMBL28823746 0.70 GRIA1 (0.52) GRIA2GRIA1GRIA3GRIA4PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0647137-B1 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF UNIV CALIFORNIA (US) 2008-08-13 EP disclosed
US-5622952-A NERVOUS SYSTEM DISORDERS; ADMINISTERING 1,4-DIHYDROQUINOXALINE-2,3-DIONE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-22 US disclosed
US-5620979-A TREATING NEURONAL LOSS ASSOCIATED WITH STROKE, ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA OR SURGERY STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-15 US disclosed
US-5514680-A ANTICONVULSANTS WITH 5,6,7-TRISUBSTITUTED-1,4-DIHYDROQUINOXALINE-2,3-DIONE THE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY (US) 1996-05-07 US disclosed
WO-1994000124-A1 GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF WEBER ECKARD (US) 1994-01-06 WO disclosed